PYRROLO[2,3-D]PYRIMIDINDERIVATE

European patent · EP4157845 · In force

Register entry

Publication number
EP4157845
Application number
EP21729021
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 25, 2021
Published
Apr 5, 2023
Granted
Aug 13, 2025
Protection ends at the latest
May 24, 2041
Next annual fee due
May 31, 2026
IPC classes
C07D 487/04 (2006.01)
A61P 1/04 (2006.01)
A61P 3/10 (2006.01)
A61P 5/14 (2006.01)
A61P 7/00 (2006.01)
A61P 9/00 (2006.01)
A61P 11/00 (2006.01)
A61P 13/12 (2006.01)
A61K 31/5377 (2006.01)
Priority
US 202062704796 P 28.05.2020
US 202063037366 P 10.06.2020
PCT application
PCT/IB2021/054516 25.05.2021
PCT publication
WO2021/240356 02.12.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 24, 2026

    Change

    Published in Swissreg on 24.06.2026

  2. Aug 13, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.08.2025

Parties

Inventor

DOWTY, Martin Eugene

Cambridge, Massachusetts 02139, US

MALHOTRA, Bimal Kumar

New York, New York 10017, US

SAMARDJIEV, Ivan Jordan

Groton, Connecticut 06340, US

SAMAS, Brian Matthew

Groton, Connecticut 06340, US

STROHBACH, Joseph Walter

Cambridge, Massachusetts 02139, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.